Cash from Operations (TTM) Chart

Historical Cash from Operations (TTM) Data

View and export this data back to 2016. Start Trial.
Date Value
June 30, 2026 -80.92M
March 31, 2026 -81.46M
December 31, 2025 -77.24M
September 30, 2025 -65.09M
June 30, 2025 -29.59M
March 31, 2025 -28.89M
December 31, 2024 -35.16M
September 30, 2024 -36.85M
June 30, 2024 -34.96M
March 31, 2024 -28.98M
December 31, 2023 -18.64M
September 30, 2023 -17.09M
June 30, 2023 -27.77M
March 31, 2023 -36.74M
December 31, 2022 -48.61M
September 30, 2022 -54.47M
June 30, 2022 -53.70M
March 31, 2022 -55.51M
December 31, 2021 -47.91M
September 30, 2021 -32.96M
Date Value
June 30, 2021 -26.60M
March 31, 2021 -24.28M
December 31, 2020 -23.36M
September 30, 2020 -32.55M
June 30, 2020 -33.97M
March 31, 2020 -34.01M
December 31, 2019 -26.19M
September 30, 2019 -29.76M
June 30, 2019 -27.57M
March 31, 2019 -24.01M
December 31, 2018 -28.72M
September 30, 2018 -25.02M
June 30, 2018 -25.86M
March 31, 2018 -28.18M
December 31, 2017 -22.11M
September 30, 2017 -21.89M
June 30, 2017 -20.24M
March 31, 2017 -18.82M
December 31, 2016 -17.74M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (TTM) Range, Past 5 Years

View Cash from Operations (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (TTM) Benchmarks

View Cash from Operations (TTM) Benchmarks
Start Trial
Lifecore Biomedical, Inc. --
Codexis, Inc. -10.40M
Frontage Holdings Corp. 46.81M
Repligen Corp. 134.86M
Bio-Techne Corp. 292.07M